Frederick Beddingfield III, President & CEO at Sienna Biopharmaceuticals, Inc. (SNNA), bought 40,000 shares at $2.50 ($100K) on 2019-02-22, disclosed to the SEC on 2019-02-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| KYTH | SELL | 2015-04-30 | $93K | — | Filing → |